Bisphosphonate Related Osteonecrosis of Jaw on Mandibular Molar Area: a Case Report

하악 구치부에 발생한 Bisphosphonate Related Osteonecrosis of Jaw의 치험례

  • Park, Jae-An (Department of Oral and Maxillofacial Surgery, Sanggye Paik Hospital, Inje University) ;
  • Yoon, Kyu-Ho (Department of Oral and Maxillofacial Surgery, Sanggye Paik Hospital, Inje University) ;
  • Cheong, Jeong-Kwon (Department of Oral and Maxillofacial Surgery, Sanggye Paik Hospital, Inje University) ;
  • Bae, Jung-Ho (Department of Oral and Maxillofacial Surgery, Sanggye Paik Hospital, Inje University) ;
  • You, Kyung-Ha (Department of Oral and Maxillofacial Surgery, Sanggye Paik Hospital, Inje University) ;
  • Jo, Kyu-Hong (Department of Oral and Maxillofacial Surgery, Sanggye Paik Hospital, Inje University) ;
  • Shin, Jae-Myung (Department of Oral and Maxillofacial Surgery, Ilsan Paik Hospital, Inje University) ;
  • Baik, Jee-Seon (Department of Oral and Maxillofacial Surgery, Ilsan Paik Hospital, Inje University)
  • 박재안 (인제대학교 상계백병원 구강악안면외과학교실) ;
  • 윤규호 (인제대학교 상계백병원 구강악안면외과학교실) ;
  • 정정권 (인제대학교 상계백병원 구강악안면외과학교실) ;
  • 배정호 (인제대학교 상계백병원 구강악안면외과학교실) ;
  • 유경하 (인제대학교 상계백병원 구강악안면외과학교실) ;
  • 조규홍 (인제대학교 상계백병원 구강악안면외과학교실) ;
  • 신재명 (인제대학교 일산백병원 구강악안면외과학교실) ;
  • 백지선 (인제대학교 일산백병원 구강악안면외과학교실)
  • Received : 2010.04.16
  • Accepted : 2010.07.23
  • Published : 2010.09.30

Abstract

Bisphosphonates are synthetic analogue and have high affinity on bone remodeling site. Since they have a long half-reduction time, they accumulate at bone and act for a long time. They are widely used in osteo-porosis derived from imflammatory bowel disease or postmenopausal osteoporosis patient for bone mineral density improvement. In addition, they neutralize hypercalcemia owing to bone metastasis of malignancy. However, a jaw bone necrosis was recently reported in some patients who have taken bisphosphonates for a long time. It is called Bisphosphonate Related Osteonecrosis of Jaws (BRONJ). It can come spontaneous-ly, but more often after oral surgery including tooth extraction. In this case, a 80-year-old woman was treated with bisphosphonate (sodium alendronate) for 2 years to improve bone mineral density. She had her left lower second molar tooth extracted at local clinic. After extraction, she had inflammatory symptoms like a pain, a cheek swelling, and a discharge of pus. She was referred to our clinic for treatment. We treated meticulously from dressing to surgery. After following up about 1.5 years, the jaw lesion was successfully healed. So we report this case.

Keywords

References

  1. Bhoomi Mehrotra : Bisphosphonates-Role in Cancer Therapies. J Oral Maxillofac Surg 67 : 19, 2009. https://doi.org/10.1016/S0278-2391(09)01878-3
  2. Marx RE : Pamidronate(AREDIA) and zolendronate (ZOMETA) induced avascular necrosis of the jaws : a growing epidemic. J Oral Maxillofac Surg 61 : 1115, 2003. https://doi.org/10.1016/S0278-2391(03)00720-1
  3. Salvatore J, Rubggiero : AAOMS Position paper on bisphosphonate-related osteonecrosis of the jaws -2009 update, American Association of Oral and Maxillofacial surgery, 2009.
  4. Korea endocrine society : Bisphosphonate Related Osteonecrosis of the Jaw (BRONJ)-Position Statement of Korea. J Kor Endocr Soc 24 : 227, 2009. https://doi.org/10.3803/jkes.2009.24.4.227
  5. Ruggiero SL, Fantasia J, Carlson E : Bisphosphonate-Related Osteonecrosis of the Jaw : background and guide-lines for diagnosis, staging and management, Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102 : 433, 2006. https://doi.org/10.1016/j.tripleo.2006.06.004
  6. Yoh Sawatari, Robert E. Marx : Bisphosphonates and Bisphosphonate Induced Osteonecrosis, Oral Maxillofacial Surg Clin N Oral Maxillofacial Surg Clin N Am 19 : 487, 2007.
  7. Lehenkari PP, Kellinsalmi M, Napankangas JP et al : Further insight into mechanism of action of clodronate : inhibition of mitochondrial ADP/ATP translocase by a nonhydrolyzable, adenine-containing metabolite, Mol Pharmaco 62 : 1255, 2002.
  8. Reid IR : Bisphosphonates: new indications and methods of administration. Curr Opin Rheumatol 15 : 4585, 2003.
  9. Paul K, Piper Jr, Ugis Gruntmanis : Management of osteoporosis in the aging male : focus on zoledronic acid. Clinical Interventions in Aging 4 : 289, 2009.
  10. Robert E. Marx : Reconstruction of Defects Caused by Bisphosphonate-Induced Osteonecrosis of the Jaws. J Oral Maxillofac Surg 67 : 107, 2009.
  11. Donoghue AM : Bisphosphonates and osteonecrosis : analogy to phossy jaw. Med J Aust183 : 163, 2005.
  12. Purcell PM, Boyd IW : Bisphosphonate and osteonecrosis of jaw. Med J Aust 182 : 417, 2005.
  13. Hellstein JW, Marek CL : Bisphosphonate osteochemone-crosis (bis-phossy jaw): Is this phossy jaw of the 21st century? J. OralMaxillofac Surg 63 : 682, 2005.
  14. Marx RE : Uncovering the cause of "phossy jaw"circa 1885 to 1906: oral and maxillofacial surgery closed case files case closed. J Oral Maxillofac Surg 66 : 2356, 2008. https://doi.org/10.1016/j.joms.2007.11.006
  15. Miles AEW : Phosphorus necrosis of the jaws:"phossy jaw."Br Dent J 133 : 203, 1972. https://doi.org/10.1038/sj.bdj.4802906
  16. Allen MR, Burr DB : Mandible matrix necrosis in beagle dogs after 3 years of daily oral bisphosphonate treatment, J Oral Maxillofac Surg 66 : 987, 2008. https://doi.org/10.1016/j.joms.2008.01.038
  17. Reid IR, Bolland MJ, Grey AB : Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity? Bone 41 : 318, 2007. https://doi.org/10.1016/j.bone.2007.04.196
  18. Ruggiero SL, Fantasia J, Carlson E : Bisphosphonaterelated osteonecrosis of the jaw : background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102 : 433, 2006. https://doi.org/10.1016/j.tripleo.2006.06.004
  19. Matthew R. Allen, David B et al : The Pathogenesis of Bisphosphonate-Related Osteonecrosis of the Jaw : So Many Hypotheses, So Few Data, 2009 American
  20. John E. Fantasia : Bisphosphonates What the Dentist Needs to Know : Practical Considerations, J Oral Maxillofac Surg 67 : 53, 2009.
  21. Freiberger JJ : Utility of Hyperbaric oxygen in treatment of Bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 67 : 96, 2009.